SOX17 and pulmonary arterial hypertension: In mice, Sox17 deficiency in pulmonary endothelial cells promotes the development of PAH under hypoxia by enhancing hypermuscularization and inflammation, while also increasing hepatocyte growth factor/mesenchymal–epithelial transition factor signaling [77].